Thanks to Alisenoc, cancer patients will have high-quality nutritional supplements with novel ingredients and with a wide range of flavors.
With the aim of improving nutritional status
and the quality of life of patients.
Con el objetivo de mejorar el estado nutricional y la calidad de vida de los pacientes.
For its scientific validation, a clinical trial will be carried out with the participation of the following entities:
The Alisenoc project is co-financed by the CDTI with ERDF funds from the European Union.
For more information about our products, call us on the phone (+34) 928 223 717 or
Copyright © 2024 Adventia Pharma. Todos los derechos reservados.